TdC 207: Pré-diabetes episode artwork

EPISODE · Oct 11, 2023 · 16 MIN

TdC 207: Pré-diabetes

from Ta de Clinicagem · host tadeclinicagem

🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨Joanne, Fred e Nathalie discutem sobre o diagnóstico de pré-diabetes, as diferenças em pacientes idosos e o tratamento com MEV e metformina.  Minutagem:(00:00) Apresentação(01:44) Diagnóstico de Pré-Diabetes(02:43) Quais exames pedir para diagnóstico? (04:30) Porque tratar o pré-diabetes?(06:04) Evolução do pré-diabetes em idosos(07:20) Tratamento não farmacológico(09:36) Tratamento farmacológico(11:15) Comparação entre tratamento não farmacológico e farmacológico(12:15) Possibilidade de interrupção da terapia medicamentosa(13:13) Outros medicamentos(14:40) Salves(15:11) Encerramento Referências:1. Cobas, Roberta, et al. "Diagnóstico do diabetes e rastreamento do diabetes tipo 2." Diretriz Oficial da Sociedade Brasileira de Diabetes (2022): 557753-2022. 2. Zhang, Xuanping, et al. "A1C level and future risk of diabetes: a systematic review." Diabetes care 33.7 (2010): 1665-1673.3. Rooney, Mary R., et al. "Risk of progression to diabetes among older adults with prediabetes." JAMA internal medicine 181.4 (2021): 511-519. 4. Jesudason, David R., et al. "Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA1c for cost-effective screening." Diabetes care 26.2 (2003): 485-490.5. ElSayed, Nuha A., et al. "Summary of revisions: Standards of Care in Diabetes—2023." Diabetes Care 46.Supplement_1 (2023): S5-S9. 6. Knowler, William C., et al. "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin." (2002): 393. 7. Hamman, Richard F., et al. "Effect of weight loss with lifestyle intervention on risk of diabetes." Diabetes care 29.9 (2006): 2102-2107.8. Chiasson, Jean-Louis, et al. "Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial." The Lancet 359.9323 (2002): 2072-2077. 9. DeFronzo, Ralph A., et al. "Pioglitazone for diabetes prevention in impaired glucose tolerance." New England Journal of Medicine 364.12 (2011): 1104-1115. 10. Spence, J. David, et al. "Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance." Diabetes, Obesity and Metabolism 24.6 (2022): 1150-1158. 11. Torgerson, Jarl S., et al. "XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients." Clinical Diabetology 5.2 (2004): 95-104.12. Le Roux, Carel W., et al. "3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial." The Lancet 389.10077 (2017): 1399-1409. 13. Pittas, Anastassios G., et al. "Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials." Annals of internal medicine 176.3 (2023): 355-363.

Joanne, Fred e Nathalie discutem sobre o diagnóstico de pré-diabetes, as diferenças em pacientes idosos e o tratamento com MEV e metformina. 🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨 🔴 Junte-se aos mais de 3.000 assinantes. Assine o Guia, ganhe tempo e atualize-se sem esforço. 🟠 Um serviço de revisão e atualização continuados em clínica médica. A informação que você precisa, do jeito que você prefere. 📚 Confira agora mesmo a edição aberta do Guia TdC sobre a nova diretriz de Insuficiência Cardíaca (IC) da American Heart Association (AHA): https://www.tadeclinicagem.com.br/guia/2/diretriz-de-insuficiencia-cardiaca-aha-2022/. Minutagem: (00:00) Apresentação (01:44) Diagnóstico de Pré-Diabetes (02:43) Quais exames pedir para diagnóstico?  (04:30) Porque tratar o pré-diabetes? (06:04) Evolução do pré-diabetes em idosos (07:20) Tratamento não farmacológico (09:36) Tratamento farmacológico (11:15) Comparação entre tratamento não farmacológico e farmacológico (12:15) Possibilidade de interrupção da terapia medicamentosa (13:13) Outros medicamentos (14:40) Salves (15:11) Encerramento Referências: 1. Cobas, Roberta, et al. "Diagnóstico do diabetes e rastreamento do diabetes tipo 2." Diretriz Oficial da Sociedade Brasileira de Diabetes (2022): 557753-2022. 2. Zhang, Xuanping, et al. "A1C level and future risk of diabetes: a systematic review." Diabetes care 33.7 (2010): 1665-1673. 3. Rooney, Mary R., et al. "Risk of progression to diabetes among older adults with prediabetes." JAMA internal medicine 181.4 (2021): 511-519. 4. Jesudason, David R., et al. "Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA1c for cost-effective screening." Diabetes care 26.2 (2003): 485-490. 5. ElSayed, Nuha A., et al. "Summary of revisions: Standards of Care in Diabetes—2023." Diabetes Care 46.Supplement_1 (2023): S5-S9. 6. Knowler, William C., et al. "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin." (2002): 393. 7. Hamman, Richard F., et al. "Effect of weight loss with lifestyle intervention on risk of diabetes." Diabetes care 29.9 (2006): 2102-2107. 8. Chiasson, Jean-Louis, et al. "Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial." The Lancet 359.9323 (2002): 2072-2077. 9. DeFronzo, Ralph A., et al. "Pioglitazone for diabetes prevention in impaired glucose tolerance." New England Journal of Medicine 364.12 (2011): 1104-1115. 10. Spence, J. David, et al. "Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance." Diabetes, Obesity and Metabolism 24.6 (2022): 1150-1158. 11. Torgerson, Jarl S., et al. "XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study. A randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients." Clinical Diabetology 5.2 (2004): 95-104. 12. Le Roux, Carel W., et al. "3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial." The Lancet 389.10077 (2017): 1399-1409. 13. Pittas, Anastassios G., et al. "Vitamin D and risk for type 2 diabetes in people with prediabetes: a systematic review and meta-analysis of individual participant data from 3 randomized clinical trials." Annals of internal medicine 176.3 (2023): 355-363.

NOW PLAYING

TdC 207: Pré-diabetes

0:00 16:26

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Ta de Clinicagem?

This episode is 16 minutes long.

When was this Ta de Clinicagem episode published?

This episode was published on October 11, 2023.

What is this episode about?

🚨 www.tadeclinicagem.com.br/guia - Conheça o Guia TdC com 7 dias grátis 🚨Joanne, Fred e Nathalie discutem sobre o diagnóstico de pré-diabetes, as diferenças em pacientes idosos e o tratamento com MEV e metformina.  Minutagem:(00:00)...

Can I download this Ta de Clinicagem episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!